Skip to main content
logo
Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
19.84
-0.44 (-2.17%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Assembly Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
74.8572.328.527.16-6.25
Revenue Growth
125.12%153.52%298.16%---92.09%
Cost of Revenue
63.6564.8155.9348.969.0870.15
Gross Profit
11.197.49-27.41-41.74-69.08-63.9
Selling, General & Admin
19.9919.6118.0122.9123.9328.5
Operating Expenses
19.9919.6118.0122.9123.9328.5
Operating Income
-8.8-12.12-45.42-64.65-93.01-92.4
Interest & Investment Income
8.7665.573.451.020.3
EBT Excluding Unusual Items
-0.04-6.12-39.85-61.2-91.99-92.1
Merger & Restructuring Charges
-----1.11.35
Impairment of Goodwill
------12.6
Asset Writedown
------0.04
Pretax Income
-0.04-6.12-39.85-61.2-93.09-132.39
Income Tax Expense
--0.330.03--2.53
Net Income
-0.04-6.12-40.18-61.23-93.09-129.86
Net Income to Common
-0.04-6.12-40.18-61.23-93.09-129.86
Net Income Growth
------
Shares Outstanding (Basic)
16116544
Shares Outstanding (Diluted)
16116544
Shares Change
133.27%86.71%31.18%13.47%11.85%22.17%
EPS (Basic)
-0.00-0.55-6.69-13.38-23.08-36.00
EPS (Diluted)
-0.00-0.55-6.69-13.38-23.08-36.00
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-38.57-41.16-51.1522.49-84.57-96.49
Free Cash Flow Per Share
-2.36-3.67-8.524.91-20.96-26.75
Gross Margin
14.95%10.36%-96.12%---
Operating Margin
-11.76%-16.76%-159.26%-902.50%--1477.42%
Profit Margin
-0.06%-8.47%-140.87%-854.78%--2076.35%
Free Cash Flow Margin
-51.53%-56.93%-179.33%313.95%--1542.88%
EBITDA
-8.69-11.99-45.29-64.2-92.52-91.93
EBITDA Margin
-11.61%-16.58%-158.80%---
D&A For EBITDA
0.110.130.130.450.50.47
EBIT
-8.8-12.12-45.42-64.65-93.01-92.4
EBIT Margin
-11.76%-16.76%-159.26%---
SEC Filings: 10-K · 10-Q